TENAX THERAPEUTICS, INC.
TENXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for TENX. That does not mean none is planned.
Get an email about TENX's next catalysts
Track TENAX THERAPEUTICS (TENX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 1 past
TENX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.35 | FQ end Sep/2026 | Call: tbd
LEVEL Phase 3 missed primary and key secondary endpoints but showed 49% NT-proBNP reduction and 3.5 mmHg RVSP reduction overall; prespecified subgroup with lower baseline 6MWD showed 26.3 m improvement vs placebo. Statistical analyses yielded a predictive enrichment strategy applied in amended LEVEL-2 protocol; Type C meeting with FDA granted.
Market Overview
Stock performance and key metrics
Levosimendan
Hypertension Pulmonary Secondary
TNX-103
Pulmonary Hypertension
perfluorocarbon emulsion (Oxycyte) infusion
Traumatic Brain Injury
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Levosimendan | Phase 3 | Hypertension Pulmonary Secondary | - | - |
TNX-103 | Phase 3 | Pulmonary Hypertension | - | - |
perfluorocarbon emulsion (Oxycyte) infusion | Phase 2 | Traumatic Brain Injury | - | - |
Hypertension Pulmonary Secondary Heart Failure
1 drug in this indication
Pulmonary Hypertension
1 drug in this indication
Hypertension Pulmonary Secondary
1 drug in this indication
Coronary Artery Bypass Grafting
1 drug in this indication
Traumatic Brain Injury
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in TENAX THERAPEUTICS, INC.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in TENAX THERAPEUTICS, INC.'s (TENX) pipeline across Phase 3, Phase 2. Its lead program is Levosimendan (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is TENAX THERAPEUTICS, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for TENAX THERAPEUTICS, INC. (TENX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TENX biotech catalysts?→
Add TENX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow TENAX THERAPEUTICS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.